Thomas Knott
Directeur Général chez Cytocentrics Bioscience GmbH
Postes actifs de Thomas Knott
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Cytocentrics Bioscience GmbH
 Cytocentrics Bioscience GmbH Pharmaceuticals: MajorHealth Technology Cytocentrics Bioscience GmbH is a German pharmaceutical manufacturing company. The private company is based in Cologne, Germany. The company was founded in 2011. Thomas Knott has been the CEO of the company since 2017. | Directeur Général | 19/06/2017 | - |
Historique de carrière de Thomas Knott
Anciens postes connus de Thomas Knott
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Cytocentrics AG
 Cytocentrics AG Medical/Nursing ServicesHealth Services Cytocentrics AG provides a tool for automated patch-clamp and ion channel screening services for drug research. Its products include CytoPatch, CytoPatch Chip, Cell Lines, Microsieves, Microchip, MEA, CP software, cell reservoir and instant cells. The firm's services include device service, cell line development, instant cells, screening services, specific assay development, GLP screening, micro systems technology and assay development for standardizes cell liners. Cytocentrics has locations in Germany and Netherlands. The company was founded in 2001 by Thomas Knott and Alfred Stett and is headquartered in Rostock, Germany. | Directeur Technique/Scientifique/R&D | 06/03/2013 | 08/03/2013 |
| Fondateur | 26/11/2009 | 08/03/2013 | |
| INVENTABIOTECH INC. | Directeur/Membre du Conseil | 01/04/2018 | - |
| Directeur Technique/Scientifique/R&D | 19/03/2018 | - |
Formation de Thomas Knott
| Eberhard Karls Universität Tübingen | Doctorate Degree |
Statistiques
Internationale
| Allemagne | 4 |
| Etats-Unis | 2 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 2 |
| Founder | 1 |
| Doctorate Degree | 1 |
Sectorielle
| Health Services | 2 |
| Consumer Services | 2 |
| Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Cytocentrics AG
Cytocentrics AG Medical/Nursing ServicesHealth Services Cytocentrics AG provides a tool for automated patch-clamp and ion channel screening services for drug research. Its products include CytoPatch, CytoPatch Chip, Cell Lines, Microsieves, Microchip, MEA, CP software, cell reservoir and instant cells. The firm's services include device service, cell line development, instant cells, screening services, specific assay development, GLP screening, micro systems technology and assay development for standardizes cell liners. Cytocentrics has locations in Germany and Netherlands. The company was founded in 2001 by Thomas Knott and Alfred Stett and is headquartered in Rostock, Germany. | Health Services |
InventaBiotech, Inc.
 InventaBiotech, Inc. Miscellaneous Commercial ServicesCommercial Services InventaBiotech, Inc. operated as a marketing, media, and investor relations consultant to public and private companies. The company was founded on October 18, 2007 and was headquartered in San Antonio, TX. | Commercial Services |
Cytocentrics Bioscience GmbH
Cytocentrics Bioscience GmbH Pharmaceuticals: MajorHealth Technology Cytocentrics Bioscience GmbH is a German pharmaceutical manufacturing company. The private company is based in Cologne, Germany. The company was founded in 2011. Thomas Knott has been the CEO of the company since 2017. | Health Technology |
- Bourse
- Insiders
- Thomas Knott
- Expérience
